Strauss Surgical
Strauss Surgical is a Miami-based medical device manufacturer founded in 2023 that designs and sells bipolar electrosurgical resection systems, HD cystoscopes, and surgical instruments across urology, hysteroscopy, and arthroscopy, targeting urologists and healthcare facilities through direct B2B sales.
- Company typePrivate
- Founded2023
- HeadquartersMiami, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Strauss Surgical does
Strauss Surgical is a privately held medical device manufacturer headquartered in Miami, Florida, that designs, produces, and sells electrosurgical resection systems and endoscopic surgical instruments across three specialties: urology, hysteroscopy, and arthroscopy. The company's flagship offering is a bipolar resection system for prostate and bladder resection, which it positions as the first major innovation in this product category in over a decade. Core technologies include a high-flow resection sheath with a ceramic beak featuring 360-degree perforations delivering 30 percent better irrigation flow, an integrated all-in-one cable/electrode solution that eliminates the cost and liability of reusable power cables, and Ultra High Definition cystoscopes for procedural visualization. The firm also manufactures laser-welded HD endoscopes and a broader instrument portfolio spanning semi-rigid ureteroscopes, DVIU/urethrotomy tools, hysteroscopes and diagnostic/operative sets, arthroscopes, knee instruments, and suture passers, supported by ISO 13485:2016 quality system certification.
The business operates a sales-led, direct B2B go-to-market motion, engaging urologists and healthcare facilities through website contact forms that capture facility details, titles, current instrumentation, and product interest. Revenue is generated primarily through one-time hardware sales of capital surgical equipment, consumables, accessories, and OEM service and repair contracts. Pricing is quote-based with multi-year contract structures, and the company emphasizes compatibility of its working elements with existing instrument sets to minimize transition costs for adopting facilities. Founded in 2023 under founder and CEO Charlie Bourland, the firm maintains a team of 1-10 employees, has no disclosed institutional investors, parent company, or partnership activity, and operates as a domestic-only, single-country entity with no M&A or funding history disclosed.
Strauss Surgical firmographics
Firmographics- Name
- Strauss Surgical
- Legal name
- Strauss Surgical
- Website
- https://straussurgical.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Strauss Surgical is a Miami-based medical device manufacturer founded in 2023 that designs and sells bipolar electrosurgical resection systems, HD cystoscopes, and surgical instruments across urology, hysteroscopy, and arthroscopy, targeting urologists and healthcare facilities through direct B2B sales.
- Ownership category
- akta.pro rank
Strauss Surgical industry classification
Industry- Product category
- Medical Devices — Surgical Instruments
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
- akta.pro secondary industries
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Orthopedic Surgery (Operative Orthopedics) (HLAKALAC)
Keywords
Where Strauss Surgical is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Markets served
Strauss Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Hardware Sales: Strauss Surgical generates revenue through the sale of medical surgical devices including bipolar resection systems, cystoscopes, high-flow sheaths, and related accessories. The revenue model is based on one-time hardware purchases for surgical equipment used in urology procedures. Given the capital equipment nature of the products and the emphasis on compatibility with existing instrument sets, the company likely also generates revenue through replacement parts, accessories, and service/repair offerings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for bipolar resection systems and accessories |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Strauss Surgical product offering
Product offeringCore offering
Strauss Surgical manufactures and sells bipolar resection systems, high-flow resection sheaths, UHD/HD cystoscopes, ureteroscopes, and related surgical instruments used by urologists and other surgical specialists. The company's core offering centers on its Bipolar Resection System for prostate and bladder procedures, supported by complementary instrumentation for arthroscopy and hysteroscopy specialties. Products are sold directly to healthcare facilities and urology practices via a consultative B2B sales model.
Product overview
Strauss Surgical is a medical device company offering a portfolio of surgical visualization and instrumentation products across three main specialties: Arthroscopy, Hysteroscopy, and Urology. The core product is the Bipolar System for prostate and bladder resection, which represents the company's first major innovation in this category since 2023. This is complemented by High-Flow Sheathing with ceramic beak technology for improved irrigation, and UHD/HD Cystoscopes for superior visualization. The product line includes arthroscopes, knee instruments, suture passers, hysteroscopes, diagnostic and operative sets, forceps, electrodes, monopolar and bipolar resection equipment, semi-rigid ureteroscopes, and DVIU/urethrotomy instruments, all supported by specialty-specific accessories. The company emphasizes that working elements are agnostic to existing instrument sets, allowing urologists to use current instrumentation while transitioning to the Strauss Surgical Bipolar solution.
Differentiator
Problem solved
Functional benefit
Products and services
- Bipolar System Bipolar resection solution for prostate and bladder resection procedures, providing efficient and concise use of bipolar energy through an all-in-one cable/electrode design. Designed for urologists seeking a modern alternative to traditional bipolar systems.
- High-Flow Sheathing Resection sheaths for urology procedures featuring irrigation inflow aligned with multiple inner sheath windows, a ceramic beak with 360° perforations for 30% better flow, and a yellow snap lock connection for easy inner sheath removal.
- UHD (Ultra High Definition) Cystoscopes
Companies that use Strauss Surgical
Customer profileSegments2 records
Ideal customer profiles1 record
Strauss Surgical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Strauss Surgical partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights3 records
Strauss Surgical competitors and assessment
Company assessmentDirect peers
- Hologic, Inc. Major player in women's health with a hysteroscopy franchise (MyoSure, NovaSure). Directly comparable to Strauss's hysteroscopy diagnostic/operative sets and bipolar/monopolar resection equipment.
- CONMED Corporation: Mid-cap surgical and respiratory device company with a strong urology, gynecology, and general surgery instrument portfolio including resectoscopes and electrosurgical generators. Comparable to Strauss across urology and hysteroscopy.
- Richard Wolf GmbH: Specialist in endoscopy and urological surgery, with a recognized resectoscope and bipolar resection franchise. Closely comparable mid-sized European competitor in the same urology/arthroscopy/hysteroscopy niches Strauss serves.
- Cook Medical: Specialist in urology, endoscopy, and interventional devices. Overlaps with Strauss's ureteroscopy, DVIU/urethrotomy, and broader urology accessories portfolio.
- Boston Scientific Corporation: Large urology-focused device maker with a portfolio spanning resection, stone management, and visualization. Competes directly with Strauss's bipolar resection system and urology cystoscopy/ureteroscopy products.
- Karl Storz SE & Co. KG: Long-established specialist in rigid endoscopy, cystoscopes, resectoscopes, and urological instruments. Karl Storz's bipolar/urology resection portfolio competes head-to-head with Strauss's bipolar system and cystoscopes.
Broad incumbents
- Smith+Nephew: Global orthopedics and sports medicine company with a significant arthroscopy franchise. Direct overlap with Strauss's arthroscopes, knee instruments, and suture passers.
- Olympus Corporation: Global leader in endoscopy and surgical instruments across urology, arthroscopy, and hysteroscopy. Directly overlaps with all three of Strauss Surgical's specialty franchises and represents the dominant incumbent Strauss must displace in hospital accounts.
- Stryker Corporation: Major medtech player with a strong arthroscopy and surgical instruments business. Directly competes with Strauss's arthroscopy line and adjacent urology/surgical visualization offerings.
Emerging players
- CooperSurgical: Focused women's health device company with hysteroscopy and reproductive surgery offerings. Comparable to Strauss's hysteroscopy line as a more focused, segment-specific peer.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Strauss Surgical social profiles
Digital presenceStrauss Surgical compliance and trust
Trust signalCompliance1 record
Strauss Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Strauss Surgical leadership team
Management profileNumber of profiles
Profiles1 record
Strauss Surgical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Strauss Surgical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Strauss Surgical
What does Strauss Surgical do?
Strauss Surgical manufactures and sells bipolar resection systems, high-flow resection sheaths, UHD/HD cystoscopes, ureteroscopes, and related surgical instruments used by urologists and other surgical specialists. The company's core offering centers on its Bipolar Resection System for prostate and bladder procedures, supported by complementary instrumentation for arthroscopy and hysteroscopy specialties. Products are sold directly to healthcare facilities and urology practices via a consultative B2B sales model.
Is Strauss Surgical a public or private company?
Strauss Surgical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Strauss Surgical founded?
Strauss Surgical was founded in 2023. It employs 1 to 10 people.
Where is Strauss Surgical based?
Strauss Surgical is headquartered in Miami, United States, in the North America region.
How does Strauss Surgical make money?
One revenue line is on record: medical Device Hardware Sales.
Who are Strauss Surgical's main competitors?
Direct peers on record are Hologic, Inc., CONMED Corporation, Richard Wolf GmbH, Cook Medical, Boston Scientific Corporation and Karl Storz SE & Co. KG. Broad incumbents are Smith+Nephew, Olympus Corporation and Stryker Corporation. CooperSurgical is listed as an emerging player.
Does Strauss Surgical have an API?
No public API is recorded for Strauss Surgical.
What industry is Strauss Surgical in?
Strauss Surgical's product category is Medical Devices — Surgical Instruments. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.